Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combined Molnupiravir and Nirmatrelvir Treatment Improves the Inhibitory Effect on SARS-CoV-2 in Rhesus Macaques
Kyle Rosenke, Matt C. Lewis, Friederike Feldmann, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 10

Showing 10 citing articles:

Triple Combination Therapy With 2 Antivirals and Monoclonal Antibodies for Persistent or Relapsed Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Patients
Małgorzata Mikulska, Chiara Sepulcri, Chiara Dentone, et al.
Clinical Infectious Diseases (2023) Vol. 77, Iss. 2, pp. 280-286
Open Access | Times Cited: 89
SARS-CoV-2 Drug Resistance and Therapeutic Approaches
Sania Batool, Santosh Chokkakula, Ju Hwan Jeong, et al.
Heliyon (2025) Vol. 11, Iss. 2, pp. e41980-e41980
Open Access | Times Cited: 3
Molnupiravir: A Versatile Prodrug against SARS-CoV-2 Variants
Divya Teli, Pankti C. Balar, Kishan Patel, et al.
Metabolites (2023) Vol. 13, Iss. 2, pp. 309-309
Open Access | Times Cited: 25
B-cell-depleted patients with persistent SARS-CoV-2 infection: combination therapy or monotherapy? A real-world experience
Alessandra D’Abramo, Serena Vita, Alessia Beccacece, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 10
Bioluminescence imaging reveals enhanced SARS-CoV-2 clearance in mice with combinatorial regimens
Irfan Ullah, Fanny Escudié, Ivan Scandale, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109049-109049
Open Access | Times Cited: 6
A proof-of-concept study on the genomic evolution of Sars-Cov-2 in molnupiravir-treated, paxlovid-treated and drug-naïve patients
Claudia Alteri, Valeria Fox, Rossana Scutari, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 22
Combination Therapy with UV-4B and Molnupiravir Enhances SARS-CoV-2 Suppression
Evelyn J. Franco, George L. Drusano, Kaley C. Hanrahan, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1175-1175
Open Access | Times Cited: 7
Triple antiviral treatment for COVID-19 in an immunocompromised patient
Chiara Dentone, Małgorzata Mikulska, Chiara Sepulcri, et al.
Journal of Antimicrobial Chemotherapy (2023) Vol. 78, Iss. 8, pp. 2097-2099
Closed Access | Times Cited: 6
Mercapto-pyrimidines are reversible covalent inhibitors of the papain-like protease (PLpro) and inhibit SARS-CoV-2 (SCoV-2) replication
Teena Bajaj, Eddie Wehri, Rahul K. Suryawanshi, et al.
RSC Advances (2023) Vol. 13, Iss. 26, pp. 17667-17677
Open Access | Times Cited: 4
Combinatorial Regimens Augment Drug Monotherapy for SARS-CoV-2 Clearance in Mice
Irfan Ullah, Fanny Escudié, Ivan Scandale, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Page 1

Scroll to top